Overview

Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of CLP on serum potassium and signs and symptoms of fluid overload in heart failure patients with chronic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
Sorbent Therapeutics
Collaborator:
Pharmaterra